Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
03/2014
03/18/2014US8673898 Aminodiazepines as toll-like receptor modulators
03/18/2014US8673897 Benzodiazepinone compounds and methods of treatment using same
03/13/2014WO2014037313A1 Use of substituted benzodiazepinones and benzazepinones or the salts thereof as active substances against abiotic plant stress
03/13/2014US20140073633 Inhibitors of the shiga toxins trafficking through the retrograde pathway
03/12/2014CN102026987B Therapeutic agent for pain
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/04/2014US8664217 Benzodiazepine compound and pharmaceutical composition
02/2014
02/26/2014CN103601690A 3-phenylbis(benzodiazepine)-1-one series derivatives, and preparation method and application thereof
02/26/2014CN103601689A Method of synthesizing dibenzodihydro-1,3-diazepine derivatives
02/20/2014WO2014026997A1 2,3-benzodiazepines
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
02/06/2014US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines
02/06/2014US20140038945 Piperazine pde4 inhibitors and uses thereof
02/04/2014US8642610 Dual small molecule inhibitors of cancer and angiogenesis
01/2014
01/29/2014EP2688873A1 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
01/28/2014US8637500 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
01/22/2014CN102112451B Diazepan and piperazine derivatives modulators of chemokine receptors
01/15/2014CN103508965A Synthetic method for dibenzepin derivative
01/14/2014US8629136 Bisfluoroalkyl-1,4-benzodiazepinone compounds
01/14/2014US8629132 Kinase inhibitors
01/09/2014US20140011988 Dibenzo[B,F][1,4]Oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors
01/08/2014CN103497114A NMDA receptor antagonists for neuroprotection
01/08/2014CN103497098A Preparation method of Tofisopam intermediate
01/07/2014US8623867 Cyclic amine BACE-1 inhibitors having a benzamide substituent
01/07/2014US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
01/07/2014US8623857 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
01/03/2014WO2012129356A3 Improved photovoltaic sheathing element with one or more tabs
01/02/2014US20140005176 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
12/2013
12/31/2013US8618283 Ligand libraries for screening GPCRs
12/25/2013CN102171183B Organic compounds
12/11/2013CN103435562A 6-substituted benzodiazepine-2,4-diketone compound and application thereof
12/10/2013US8604023 1,4-benzodiazepinone compounds and their use in treating cancer
12/03/2013US8598346 Synthesis of cyclic amidines
12/03/2013US8598160 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/03/2013US8598159 Therapeutic pyrazoloquinoline derivatives
12/03/2013CA2658327C Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
11/2013
11/27/2013EP2665724A1 Bicyclic inhibitors of alk
11/27/2013CN103415516A Bicyclic inhibitors of ALK
11/27/2013CN103408504A Clozapine crystal compound, nanometer rapidly disintegrating tablet and preparation methods of clozapine crystal compound, a nanometer rapidly disintegrating tablet
11/20/2013EP2663555A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2307387B1 Novel heterocyclyl compounds for treatment of cardiovascular disease
11/20/2013CN101506196B Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
11/19/2013US8586577 Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors
11/19/2013US8586576 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/14/2013WO2013167177A1 Gpr17 receptor modulators.
11/12/2013US8580782 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11/12/2013CA2680017C Compositions and methods relating to novel compounds and targets thereof
11/07/2013US20130296551 7-membered ring compound and method of production and pharmaceutical application thereof
10/2013
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/29/2013US8569289 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
10/24/2013US20130281441 Diazepinedione derivative
10/23/2013CN103360330A Synthetic method for homopiperazine
10/22/2013US8563576 Tri-cyclic pyrazolopyridine kinase inhibitors
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/17/2013US20130274197 Benzodiazepinone compounds useful in the treatment of skin conditions
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/09/2013EP2646421A1 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1h-benzo[e][1,4]diazepin-2(3h)-one and other benzodiazepine derivatives
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8551982 Benzodioxane inhibitors of leukotriene production
10/08/2013CA2667826C Inhibitors of histone deacetylase
10/03/2013WO2013007371A3 Kinetic resolution of chiral amines
10/03/2013US20130261110 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
10/03/2013US20130261081 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
10/01/2013CA2594482C Antitumor agent
09/2013
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013US8540966 Contrast agents endowed with high relaxivity
09/19/2013WO2013135750A1 A new class of diazepine derivative chelating agents and complexes with paramagnetic metals thereof as mri contrast agents
09/18/2013EP2639227A1 A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents
09/18/2013EP2638020A1 Transamination of nitrogen-containing compounds to make cyclic and cyclic/acyclic polyamine mixtures
09/18/2013CN102006873B Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/17/2013US8536168 Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
09/12/2013US20130237529 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
09/05/2013US20130231332 Small molecule inhibitors of ebola and lassa fever viruses and methods of use
09/04/2013CN103275067A Inhibitors of histone deacetylase
08/2013
08/29/2013WO2013126797A1 Cholecystokinin b receptor targeting for imaging and therapy
08/29/2013US20130225565 2,5-disubstituted arylsulfonamide ccr3 antagonists
08/29/2013US20130225563 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
08/27/2013US8518936 Method for preparing acid addition salts of polyacidic basic compounds
08/22/2013WO2013123217A1 Small molecules that enhance the activity of oligonucleotides
08/21/2013CN103261174A Transamination of nitrogen-ontaining compounds to make cyclic and cyclic/acyclic polyamine mixtures
08/21/2013CN101203500B Substituted arylamine compounds and uses as 5-HT6 moderator thereof
08/20/2013US8513239 Chiral cis-imidazolines
08/06/2013US8501750 Heterocyclic compound and use thereof
08/06/2013US8501732 Aminomethyl quinolone compounds
08/01/2013WO2013110134A1 Heterocyclic compounds and methods for their use
07/2013
07/30/2013CA2659549C Compositions and methods relating to novel compounds and targets thereof
07/25/2013US20130190300 Compositions and methods for inhibiting the proliferation of cells
07/24/2013EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
07/23/2013US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
07/18/2013WO2013105608A1 P2x4 receptor antagonist
07/18/2013US20130184263 Derivatives of Betulin
07/17/2013CN103204819A Deuterated diazepam and preparation method thereof
07/16/2013US8487093 β-lactamase inhibitors
07/16/2013CA2485592C Anti tubercular drug: compositions and methods
07/11/2013US20130178420 Novel glp-1 receptor modulators
07/09/2013US8481722 High stability polyionic liquid salts
07/04/2013US20130172550 P2x4 receptor antagonist
07/03/2013EP2610252A1 Novel production method for isoquinoline derivatives and salts thereof
07/03/2013CN103184054A Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polymer and compound
1 2 3 4 5 6 7 8 9 10 11 12 ... 60